David H. Koch donates $10 million to Mount Sinai's Jaffe Food Allergy Institute

Public release date: 10-Apr-2012
[ | E-mail | Share ]

Contact: Jeanne Bernard
Jeanne.Bernard@mountsinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

David H. Koch, Executive Vice President of Koch Industries, has committed $10 million to the Jaffe Food Allergy Institute at The Mount Sinai Medical Center. The gift is one of the largest in the Institute's history and will create the David H. and Julia Koch Research Program in Food Allergy Therapeutics. The program will serve as a hub for drug discovery and vaccine development related to food allergy, and build upon the promising work already underway at the Institute. The donation will also be used to further the Institute's recruitment of leading researchers dedicated to the discovery of new food allergy therapeutics.

Nearly 15 million Americans have food allergies, including approximately 6 million children, according the The Food Allergy & Anaphylaxis Network. A 2010 study led by Scott Sicherer, MD, Chief of the Division on Allergy and Immunology in the Department of Pediatrics and a clinical researcher at the Jaffe Food Allergy Institute found the rates of childhood peanut allergies, one of the most common and most dangerous food allergies, more than tripled between 1997 and 2008.

Because the preventive shots used for allergies such as pollen or bee stings cause severe unwanted side effects when used for food allergies, scientists at the Institute are conducting cutting-edge research investigating using small fragments of the three main allergenic proteins present in peanuts to create a "safe shot." If successful in preventing peanut allergy, the theory could be applied to vaccines for all food allergies. Mr. Koch's donation will support these studies as well as efforts to identify new targets and biomarkers for food allergy.

"This generous gift will strengthen Mount Sinai's position as a global leader in food allergy therapeutics," said Hugh Sampson, MD, Director of the Jaffe Food Allergy Institute and an internationally recognized allergist and investigator of food allergy. "Right now, the only recourse for patients who have food allergies is to avoid those foods. This program has the potential to deliver the first therapies and cures for food allergies."

The research conducted by the program will be especially significant for children's health, according to Kenneth L. Davis, President and CEO of The Mount Sinai Medical Center. "Breakthrough therapeutics such as these will change the face of children's health," he said. "Mr. Koch's visionary philanthropy brings us one step closer to that goal."

Mr. Koch is a major advocate for medical research, and has long supported research into food allergies. "This is an exhilarating time for science and medicine in food allergy, and Dr. Sampson and his team are the best at what they do, but the most exciting discoveries are yet to come," said Mr. Koch. "My hope is that in the not-too-distant future, children who suffer from life-threatening food allergies will have their lives transformed from the therapies that originated here."

The Jaffe Food Allergy Institute was established in 1997 with the mission to expand and improve basic science and clinical research, comprehensive patient care, and educational efforts in the field of food allergy. Recent findings and ongoing studies include:

• The group recently published a study showing that introducing food products containing baked milk into the diets of children who have milk allergy helps the majority of them outgrow their milk allergy more quickly;
• In the first-ever study to assess the social impact of food allergies in children, researchers led by Dr. Scott Sicherer, found that approximately 35 percent of children over the age of five with food allergies, experience bullying, teasing, or harassment as a result of their allergies;
• A team led by Dr. Sampson is currently conducting a clinical trial investigating the effectiveness of oral immunotherapy combined with the anti-IgE medication omalizumab in the treatment of cow's milk allergy;
• A team of investigators led by Julie Wang, MD, Assistant Professor of Allergy and Immunology and Xiu-Min Li, MD, Professor of Pediatrics, is currently conducting a clinical trial investigating the effectiveness of Chinese herbs as a treatment for peanut, tree nuts, sesame, fish, or shellfish allergies;
• A team led by Dr. Sampson is investigating other novel forms of immunotherapy including peptide-based vaccines and engineered recombinant protein-based vaccines.

By combining a world-class clinical research program with an equally strong laboratory-based one, the Jaffe Food Allergy Institute is uniquely able to move ideas and investigations between the laboratory bench and the patient's bedside in order to approach these disorders as efficiently and creatively as possible. The major goal is to devise more definitive, hopefully curative, therapies for food allergic disease.

###

To find out more about the work being done at the Jaffe Food Allergy Institute visit: http://www.mssm.edu/research/programs/jaffe-food-allergy-institute.

About The Mount Sinai Medical Center

The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of the leading medical schools in the United States. The Medical School is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report.

The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. In 2011, U.S. News & World Report ranked The Mount Sinai Hospital 16th on its elite Honor Roll of the nation's top hospitals based on reputation, safety, and other patient-care factors. Of the top 20 hospitals in the United States, Mount Sinai is one of 12 integrated academic medical centers whose medical school ranks among the top 20 in NIH funding and US News & World Report and whose hospital is on the US News & World Report Honor Roll. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place.

For more information, visit http://www.mountsinai.org/.

Find Mount Sinai on:
Facebook: http://www.facebook.com/mountsinainyc
Twitter: @mountsinainyc
YouTube: http://www.youtube.com/mountsinainy

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Public release date: 10-Apr-2012
[ | E-mail | Share ]

Contact: Jeanne Bernard
Jeanne.Bernard@mountsinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

David H. Koch, Executive Vice President of Koch Industries, has committed $10 million to the Jaffe Food Allergy Institute at The Mount Sinai Medical Center. The gift is one of the largest in the Institute's history and will create the David H. and Julia Koch Research Program in Food Allergy Therapeutics. The program will serve as a hub for drug discovery and vaccine development related to food allergy, and build upon the promising work already underway at the Institute. The donation will also be used to further the Institute's recruitment of leading researchers dedicated to the discovery of new food allergy therapeutics.

Nearly 15 million Americans have food allergies, including approximately 6 million children, according the The Food Allergy & Anaphylaxis Network. A 2010 study led by Scott Sicherer, MD, Chief of the Division on Allergy and Immunology in the Department of Pediatrics and a clinical researcher at the Jaffe Food Allergy Institute found the rates of childhood peanut allergies, one of the most common and most dangerous food allergies, more than tripled between 1997 and 2008.

Because the preventive shots used for allergies such as pollen or bee stings cause severe unwanted side effects when used for food allergies, scientists at the Institute are conducting cutting-edge research investigating using small fragments of the three main allergenic proteins present in peanuts to create a "safe shot." If successful in preventing peanut allergy, the theory could be applied to vaccines for all food allergies. Mr. Koch's donation will support these studies as well as efforts to identify new targets and biomarkers for food allergy.

"This generous gift will strengthen Mount Sinai's position as a global leader in food allergy therapeutics," said Hugh Sampson, MD, Director of the Jaffe Food Allergy Institute and an internationally recognized allergist and investigator of food allergy. "Right now, the only recourse for patients who have food allergies is to avoid those foods. This program has the potential to deliver the first therapies and cures for food allergies."

The research conducted by the program will be especially significant for children's health, according to Kenneth L. Davis, President and CEO of The Mount Sinai Medical Center. "Breakthrough therapeutics such as these will change the face of children's health," he said. "Mr. Koch's visionary philanthropy brings us one step closer to that goal."

Mr. Koch is a major advocate for medical research, and has long supported research into food allergies. "This is an exhilarating time for science and medicine in food allergy, and Dr. Sampson and his team are the best at what they do, but the most exciting discoveries are yet to come," said Mr. Koch. "My hope is that in the not-too-distant future, children who suffer from life-threatening food allergies will have their lives transformed from the therapies that originated here."

The Jaffe Food Allergy Institute was established in 1997 with the mission to expand and improve basic science and clinical research, comprehensive patient care, and educational efforts in the field of food allergy. Recent findings and ongoing studies include:

• The group recently published a study showing that introducing food products containing baked milk into the diets of children who have milk allergy helps the majority of them outgrow their milk allergy more quickly;
• In the first-ever study to assess the social impact of food allergies in children, researchers led by Dr. Scott Sicherer, found that approximately 35 percent of children over the age of five with food allergies, experience bullying, teasing, or harassment as a result of their allergies;
• A team led by Dr. Sampson is currently conducting a clinical trial investigating the effectiveness of oral immunotherapy combined with the anti-IgE medication omalizumab in the treatment of cow's milk allergy;
• A team of investigators led by Julie Wang, MD, Assistant Professor of Allergy and Immunology and Xiu-Min Li, MD, Professor of Pediatrics, is currently conducting a clinical trial investigating the effectiveness of Chinese herbs as a treatment for peanut, tree nuts, sesame, fish, or shellfish allergies;
• A team led by Dr. Sampson is investigating other novel forms of immunotherapy including peptide-based vaccines and engineered recombinant protein-based vaccines.

By combining a world-class clinical research program with an equally strong laboratory-based one, the Jaffe Food Allergy Institute is uniquely able to move ideas and investigations between the laboratory bench and the patient's bedside in order to approach these disorders as efficiently and creatively as possible. The major goal is to devise more definitive, hopefully curative, therapies for food allergic disease.

###

To find out more about the work being done at the Jaffe Food Allergy Institute visit: http://www.mssm.edu/research/programs/jaffe-food-allergy-institute.

About The Mount Sinai Medical Center

The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of the leading medical schools in the United States. The Medical School is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report.

The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. In 2011, U.S. News & World Report ranked The Mount Sinai Hospital 16th on its elite Honor Roll of the nation's top hospitals based on reputation, safety, and other patient-care factors. Of the top 20 hospitals in the United States, Mount Sinai is one of 12 integrated academic medical centers whose medical school ranks among the top 20 in NIH funding and US News & World Report and whose hospital is on the US News & World Report Honor Roll. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place.

For more information, visit http://www.mountsinai.org/.

Find Mount Sinai on:
Facebook: http://www.facebook.com/mountsinainyc
Twitter: @mountsinainyc
YouTube: http://www.youtube.com/mountsinainy

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

autism obamacare adrienne rich cesar chavez day raspberry ketone ron burgundy millennial media